XML 43 R29.htm IDEA: XBRL DOCUMENT v3.22.4
Revenue from Contracts with Customers (Tables)
12 Months Ended
Dec. 31, 2022
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue [Table Text Block] A summary by the Company’s reportable segments follows for the years ended December 31:
Twelve months ended December 31, 2022U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$1,113,983 $139,490 $581,168 $777,276 $506,804 $3,118,721 
Service Revenue:
Point in time
256,837 27,800 134,781 46,931 121,786 588,135 
Over time
73,640 8,829 83,982 17,319 29,083 212,853 
Total$1,444,460 $176,119 $799,931 $841,526 $657,673 $3,919,709 
Twelve months ended December 31, 2021U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$1,004,891 $135,987 $600,527 $707,355 $511,855 $2,960,615 
Service Revenue:
Point in time
218,306 26,764 151,656 48,343 120,860 565,929 
Over time
64,786 8,882 77,578 15,953 24,187 191,386 
Total$1,287,983 $171,633 $829,761 $771,651 $656,902 $3,717,930 
Twelve months ended December 31, 2020U.S. OperationsSwiss OperationsWestern European OperationsChinese OperationsOther OperationsTotal
Product Revenue$815,046 $112,542 $509,385 $526,231 $441,968 $2,405,172 
Service Revenue:
Point in time
199,247 22,733 135,793 39,705 110,542 508,020 
Over time
58,026 8,648 71,537 12,674 21,100 171,985 
Total$1,072,319 $143,923 $716,715 $578,610 $573,610 $3,085,177 
The Company's global revenue mix by product category for the year ended December 31, 2022 is laboratory (57% of sales), industrial (38% of sales), and retail (5% of sales). The Company’s product revenue by reportable segment is proportionately similar to the Company’s global mix with the exception of the Company’s Swiss Operations, which is largely comprised of laboratory products, and the Company’s Chinese Operations, which has a slightly higher percentage of industrial products. A breakdown of the Company’s sales by product category for the year ended December 31 follows:
202220212020
Laboratory$2,230,381 $2,083,025 $1,669,791 
Industrial1,510,554 1,446,544 1,224,497 
Retail178,774 188,361 190,889 
Total net sales$3,919,709 $3,717,930 $3,085,177 
A breakdown of net sales to external customers by geographic customer destination, net for the year ended December 31 follows:
 202220212020
Americas$1,582,493 $1,419,832 $1,180,626 
Europe1,014,360 1,062,961 921,266 
Asia/Rest of World1,322,856 1,235,137 983,285 
Total$3,919,709 $3,717,930 $3,085,177 
Contract with Customer, Asset and Liability [Table Text Block]
202220212020
Beginning balances as of January 1$192,648 $149,106 $122,489 
Customer prepayments/deferred revenue731,482 711,067 617,643 
Revenue recognized(720,362)(667,245)(595,802)
Foreign currency translation(11,009)(280)4,776 
Ending balance as of December 31$192,759 $192,648 $149,106